Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Sponsor: Bayer
Summary
The aim of the HEM-POWR study is to understand better how Damoctocog alfa pegol (Jivi) is used to treat people with Hemophilia A in day-to-day life, how well the treatment is tolerated and how satisfied patients and physicians are with the treatment.
Official title: Observational Study Evaluating Effectiveness and Safety of Real-World Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
371
Start Date
2019-10-21
Completion Date
2027-03-31
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
Damoctocog alfa pegol (Jivi, Bay94-9027)
Follow clinical practice. BAY94-9027 is a B-domain-deleted recombinant factor VIII (rFVIII) product site-specifically conjugated to a single (dual 30-kDa branched) 60-kDa polyethylene glycol (PEG) molecule. BAY 94-9027 is intended for prophylaxis and treatment of bleeds in patients with hemophilia A aged ≥12 years, with a narrow, predictable weekly dose that allows for the treatment regimen to be tailored to individual patient needs.
Locations (29)
South Alabama Medical Science Foundation
Mobile, Alabama, United States
Banner MD Anderson Cancer Center
Phoenix, Arizona, United States
University California Davis
Davis, California, United States
Orthopaedic Hospital DBA Orthopaedic Institute for Children
Los Angeles, California, United States
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders
Orange, California, United States
University of Colorado Hemophilia and Thrombosis Center
Aurora, Colorado, United States
Georgetown University
Washington D.C., District of Columbia, United States
Tulane University
New Orleans, Louisiana, United States
Regents of University of Minnesota
Minneapolis, Minnesota, United States
East Carolina University - Brody School of Medicine
Greenville, North Carolina, United States
Many locations
Multiple Locations, Belgium
Many locations
Multiple Locations, Brazil
Many locations
Multiple Locations, Canada
Many locations
Multiple Locations, Colombia
Many locations
Multiple Locations, Denmark
Many locations
Multiple Locations, Germany
Many locations
Multiple Locations, Greece
Many locations
Multiple Locations, Italy
Many locations
Multiple Locations, Japan
Many locations
Multiple Locations, Kuwait
Many locations
Multiple Locations, Netherlands
Many locations
Multiple Locations, Norway
Many locations
Multiple Locations, Saudi Arabia
Many locations
Multiple Locations, Slovenia
Many locations
Multiple Locations, Spain
Many locations
Multiple Locations, Sweden
Many locations
Multiple Locations, Switzerland
Many locations
Multiple Locations, Taiwan
Many locations
Multiple Locations, United Arab Emirates